| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 37 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 160.7K | $9.18M | - | |
| CEO | 133.2K | $7.60M | -18,198 | |
| CFO | 106.5K | $6.08M | - | |
| Other | 76.8K | $4.38M | -17,000 | |
| VP | 29.0K | $1.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 2,366 | $92.25 | $218,252.88 | -0.4% | -25.2% | -51.4% | |
| Dec 5, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $91.49 | $457,433.92 | -5.3% | -17.9% | -48.4% | |
| Dec 2, 2024 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $92.49 | $739,884.53 | -1.3% | -21.3% | -51.2% | |
| Dec 2, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 15,000 | $92.45 | $1,386,794.41 | -1.1% | -21.3% | -51.2% | |
| Nov 18, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $85.81 | $686,517.55 | -2.4% | -4.6% | -42.7% | |
| Nov 7, 2024 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 2,366 | $103.89 | $245,796.25 | -0.2% | -13.0% | -59.4% | |
| Nov 5, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 5,000 | $106.36 | $531,803.36 | -3.9% | -21.2% | -62.5% | |
| Nov 1, 2024 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 8,000 | $106.80 | $854,422.60 | -1.0% | -14.3% | -57.8% | |
| Nov 1, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 15,000 | $106.82 | $1,602,251.52 | -1.1% | -14.3% | -57.8% | |
| Oct 18, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 42,000 | $115.39 | $4,846,508.21 | -18.4% | -24.0% | -63.3% |